IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CARPO, MARINELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.389
NA - Nord America 7.801
AS - Asia 7.429
Continente sconosciuto - Info sul continente non disponibili 1.424
SA - Sud America 992
AF - Africa 204
OC - Oceania 99
Totale 28.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.274
GB - Regno Unito 3.267
IT - Italia 2.144
CN - Cina 2.011
SG - Singapore 1.907
RU - Federazione Russa 875
DE - Germania 818
SE - Svezia 743
JP - Giappone 611
BR - Brasile 601
VN - Vietnam 557
FR - Francia 550
TR - Turchia 450
IN - India 430
HK - Hong Kong 425
KR - Corea 384
CA - Canada 348
BD - Bangladesh 299
NL - Olanda 299
IE - Irlanda 281
UA - Ucraina 253
FI - Finlandia 222
ES - Italia 206
PL - Polonia 162
EU - Europa 149
AR - Argentina 124
CO - Colombia 119
GR - Grecia 105
MX - Messico 101
AU - Australia 90
DK - Danimarca 88
BE - Belgio 80
ID - Indonesia 76
CH - Svizzera 66
CI - Costa d'Avorio 57
CL - Cile 53
AT - Austria 50
RO - Romania 44
PT - Portogallo 36
TH - Thailandia 31
TW - Taiwan 30
IQ - Iraq 28
UY - Uruguay 25
ZA - Sudafrica 25
LY - Libia 23
TN - Tunisia 22
EC - Ecuador 20
PE - Perù 20
PK - Pakistan 20
EG - Egitto 19
MA - Marocco 18
MY - Malesia 18
PH - Filippine 17
AE - Emirati Arabi Uniti 15
GT - Guatemala 15
IR - Iran 15
VE - Venezuela 15
CR - Costa Rica 14
LB - Libano 13
SA - Arabia Saudita 13
SI - Slovenia 13
DZ - Algeria 12
IL - Israele 12
HR - Croazia 11
RS - Serbia 11
HU - Ungheria 9
JM - Giamaica 9
KE - Kenya 9
OM - Oman 9
PY - Paraguay 9
UZ - Uzbekistan 9
JO - Giordania 8
LT - Lituania 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
NP - Nepal 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
MQ - Martinica 6
NO - Norvegia 6
PS - Palestinian Territory 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
BY - Bielorussia 5
HN - Honduras 5
BG - Bulgaria 4
BO - Bolivia 4
IS - Islanda 4
LU - Lussemburgo 4
MD - Moldavia 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GA - Gabon 3
NI - Nicaragua 3
SN - Senegal 3
AM - Armenia 2
CU - Cuba 2
Totale 27.023
Salva come PNG Salva come JPEG
Città #
Southend 2.864
Singapore 1.050
Chandler 545
Seattle 520
Ashburn 481
Milan 470
San Jose 419
Hong Kong 397
Beijing 374
Council Bluffs 369
Princeton 366
Dublin 279
Wilmington 266
Santa Clara 243
Redmond 197
New York 192
Los Angeles 189
Tokyo 180
Rome 179
Redwood City 172
Toronto 156
Bengaluru 151
Ho Chi Minh City 150
Lauterbourg 148
Nanjing 147
Dallas 143
Sakarya 139
Moscow 132
Mountain View 131
Des Moines 128
Boardman 127
Jacksonville 117
Hanoi 110
Buffalo 103
Frankfurt am Main 97
Ann Arbor 96
Dearborn 90
Fairfield 81
Jinan 80
Warsaw 80
Guangzhou 79
Athens 77
Shenyang 73
São Paulo 73
Shanghai 71
Woodbridge 71
Eitensheim 70
Houston 70
Berlin 64
Paris 60
Buenos Aires 58
Abidjan 57
Hebei 56
Bogotá 54
London 53
Changsha 47
Istanbul 45
Serra 43
Munich 41
Tianjin 41
Brussels 40
Naples 39
Nanchang 38
Santiago 38
Verona 38
Bitonto 37
Cangzhou 37
Chicago 37
Madrid 37
Dong Ket 36
Hefei 36
Ottawa 36
Phoenix 36
San Diego 36
Andover 35
Helsinki 34
Barcelona 33
Mumbai 33
Columbus 32
Turin 32
Duncan 29
Philadelphia 29
Montreal 28
The Dalles 28
Zhengzhou 28
Nuremberg 27
Vienna 26
Prato 25
Florence 24
Jakarta 24
Bologna 23
Boston 23
Fuzhou 23
Jiaxing 23
Grafing 22
Medellín 22
Osaka 22
Shenzhen 22
Sydney 22
Birmingham 21
Totale 14.572
Salva come PNG Salva come JPEG
Nome #
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 4.121
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 771
Impact of environmental factors and physical activity on disability and quality of life in CIDP 664
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 647
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 637
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 367
Rilevanza diagnostica degli anticorpi antinervo nelle neuropatie disimmuni 346
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 284
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? 268
High tumor necrosis factor-alpha levels in cerebrospinal fluid of cobalamin-deficient patients 254
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation 253
Caratterizzazione molecolare dei geni CLCN1, SCN4A, KCNJ2, CACNA1S in pazienti con canalopatie muscolari 252
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 224
Neuroborreliosis mimicking a paraneoplastic syndrome 215
Polymorphisms of the TNF-alphagene in italian GBS patients 215
Stiff-Person Syndrome responding to intrathecal baclofen. 214
Survival motor neuron (SMN1 and SMN2) genes copy number in multifocal motor neuropathy 207
Changes in neuroimmunological pattern in IVIg treated-MMN patients : a long term follow up 199
Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies 192
How-long is IVIg effective in multifocal motor neuropathy? 189
Long term disability and social status change after Guillain-Barré syndrome 189
Role of TNF-alpha in modulating GBS phenotype in Italian patients 187
Long-term effect of Rituximab in antii-MAG polyneuropathy 186
A sporadic, atypical case of desminopathy: morphological and immunological characterization 184
Painful sensory neuropathy and dysimmunity: is there a relation? 184
Diagnostic relevance of anti-neural antibodies in dysimmune neuropathies 181
Molecular characterization of CLCN1, SCN4A, KCNJ2, CACNA1S genes in patients with muscle channelopathies. 180
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 180
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 173
Guillain-Barré syndrome : an Italian multicentre case-control study 169
Long term efficacy of Rituximab in anti-MAG polyneuropathy 168
Multifocal motor neuropathy with an unusual clinical presentation 165
Electrophysiological parameters associated with reponse to IVIg in multifocal motor neuropathy 164
Autoimmunity in painful sensory neuropathy 164
Polyneuropathy in POEMS syndrome : role of angiogenic factors in the pathogenesis 163
A case-control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain-Barré syndrome in Western Lombardia 162
Anti-sulfatide IgM antibodies in peripheral neuropathy 158
Anti-GM1 IgM antibodies in motor neuron disease and neuropathy 155
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation 154
Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins 153
POEMS sindrome: role of two angiogenic factors, VEGF and EPO 151
New abnormalities in the CSF of vitamin B12-deficient patients 150
Antecedent infections in Guillain Barré syndrome (GBS) in northern Italy: a clinical and serological case-control study 150
Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy 149
Detection of anti-glycolipid antibodies by a Dot-Blot analysis: could it be a valid alternative? 147
Gangliosides. Their role in clinical neurology 147
Multifocal motor neuropathy: clinical and immunological features and response to IVIg therapy in patients with definite, probable or no overt conduction block 147
Abnormal expression of cyclin-dependent kinase in an atypical case of desminopathy 147
VEGF and BFGF modulation are not involved in thalidomide-induced neuropathy 146
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia 144
Predictors of response to Rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M 142
Vascular Endotelial growth factor serum concentration and diabethic neuropathy 142
Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies 140
Anti-campylobacter jejuni lipopolysaccharide reactivity in multifocal motor neuropathy 140
Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy 139
MONOCLONAL IGMK IN A PATIENT WITH MOTOR NEURON DISEASE BINDS TO GM1, GD1B, AND TO HIGH MOLECULAR CENTRAL NERVOUS SYSTEM-SPECIFIC GLYCOCONJUGATES 138
A case control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in GBS: correlation with antecedent event and with clinical features 137
Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component 134
Is campylobacter jejuni enteritis a risk factor for Guillain Barré sindrome in Italy? A case control study by western blot in northern Italy 133
Are there immunologically treatable motor neuron diseases? 132
Different types of neuropathic pain in a large cohort of Italian patients with peripheral nervous system diseases 132
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor neuropathy (MMN) 132
Treatment of multifocal motor neuropathy 131
Anti-ganglioside and anti-Campylobacter Jejuni (CJ) antibodies in Guillain-Barré syndrome (GBS): regional and temporal variability in Italian patients 131
A case Control study of anti-ganglioside and anti-Campylobacter jejuni antibnodies in Guillain Barré syndrome in western Lombardia 131
Clinical relevance of anti-GM1 IgM antibodies 130
Anti-GD1a ganglioside antibodies in peripheral motor syndromes 129
The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize the N-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide 129
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor nuropathy (MMN) 129
Serum antibodies to campylobacter jejuni in multifocal motor neuropathy 129
Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies 128
Multifocal motor neuropathy and campylobacter jejuni reactivity 127
An atypical case of desminopathy with abnormal expression of cyclin-dependent kinase 127
Novel missense GARS gene mutation in an Italian family with hereditary distal motor neuropathy 126
Electrophysiological parameters associated with reponse to IVIg in multifocal motor neuropathy 126
Long-term effect of IVIg in multifocal motor neuropathy 126
Anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain Barré syndrome: A case control study 126
IgM reactivity with a human neuroblastoma cell line in patients with peripheral neurological disorders 126
Long-term effect of intravenous immunoglobulin therapy (IVIg) in multifocal motor neuropathy (MMN) 125
Predictive value of anti-GM1 IgM and IgG antibodies for dysimmune neuropathies 125
Neurological complication in Celiac Disease: could have an autoimmune origin? 121
Clinical and immunological study in neuropathy associated with IgG MGUS 121
Pain: a frequent and often overlooked presenting symptom in Guillain Barré syndrome 120
Anti-GD1a antibodies in motor neuropathies 120
Long-term efficacy of Rituximab in anti-MAG polyneuropathy 119
IgM reactivitry with a human neuroblsatoma cell line in patients with peripheral neurological disorders 119
Deterioration of multifocal motor neuropathy after plasma exchange 118
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 118
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy 118
Anti-GM1 antibodies in multifocal motor neuropathy : effect of intravenous immunoglobulin therapy 118
Atypical anti-neuronal reactivity in neurological disorders : could have another role besides being paraneoplastic? 117
Proximal myotonic myopathy (PROMM) syndrome without CTG expansion: a new case 117
Thalidomide-induced neuropathy is a distal axonopathy not due to VEGF inhibition 116
Residual disability and psychosocial status after Guillain Barré syndrome: a 3 to 5 year follow-up study 115
Anti-GM1 antibodies in CSF of patients with the Guillain Barre' Syndrome and motor neuropathy 115
Guillain Barre' Syndrome associated with high titers of anti-GM1 antibodies 113
Antigen specificity of the M-protein in 77 patients with neuropathy and IgM monoclonal gammopathy 113
Possible implementation of diagnostic tools in paraneoplastic neurological disorders. 112
Risk factors for Guillain Barré sindrome (GBS) in northern Italy: analysis of anamnestic antecedent events and serological evidence of infections 112
Anti-GM1 IgG antibodies in Guillain Barre' Syndrome 112
Totale 21.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.020 0 0 141 169 185 278 131 118 260 180 192 366
2022/20232.700 323 219 224 287 300 457 93 150 252 110 141 144
2023/20241.853 112 145 124 121 314 94 129 140 83 178 196 217
2024/20253.647 175 327 147 343 422 170 212 373 261 326 255 636
2025/20266.061 475 224 524 463 636 522 762 441 700 505 466 343
2026/2027782 369 406 7 0 0 0 0 0 0 0 0 0
Totale 28.338